Global Synchronized Oncology Development: Integrating High-Impact Regions to Accelerate Trial Readiness

This 60-minute webinar will focus on how sponsors can operationalize globally synchronized oncology development to accelerate timelines while maintaining consistency across regions. The session will explore how to align regulatory, clinical, and operational strategies across major markets, with a practical lens on integrating high-impact but often underutilized regions such as China into global programs.

Key topics will include:

• Translating evolving regulatory acceleration pathways into globally executable plans
• Aligning protocol design, site readiness, and ethics submissions across regions to avoid delays
• Maintaining global protocol consistency while accommodating regional requirements
• Building risk management and initiation strategies that support parallel—not sequential—development
• Leveraging regional opportunities (including China’s accelerated timelines) without disrupting global milestones

The session will emphasize execution planning that preserves global timelines while expanding patient access and data diversity across regions—a growing priority for oncology sponsors operating in increasingly complex, multi-regional environments.

Our Speakers:

• Adam Callahan, MS, MBA – VP, Global Therapeutic Area Head, Oncology & Hematology
• Ed Dow, MD – Executive Medical Director
• Susan Kong – VP Regulatory Strategic Development